Results 11 to 20 of about 740,964 (300)
Gefässchirurgie, 2020 Structural model of SARS-CoV-2 including the X rays structure of the spikes (PDB ID 6VSB). The model is composed of cryoEM density from SARS-CoV-1 for the core and SARS-CoV-2 spikes pdbs.
Dr Victor Padilla-Sanchez, PhD (8627079)
core +3 more sources
SARS‐CoV‐2 and hypertension [PDF]
Physiological Reports, 2021 The objective of this review is to give an overview of the pathophysiological effects of the Coronavirus Disease 2019 (COVID‐19) in relation to hypertension (HT), with a focus on the Renin–Angiotensin–Aldosterone System (RAAS) and the MAS receptor. HT is
Briyanth Ravichandran +5 more
doaj +4 more sources
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2 [PDF]
Advanced Science, 2020 The world is currently experiencing a global pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes severe respiratory disease similar to SARS.
Yetian Dong +4 more
doaj +3 more sources
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
Viruses, 2020 The outbreak of a novel coronavirus, which was later formally named the severe acute respiratory coronavirus 2 (SARS-CoV-2), has caused a worldwide public health crisis. Previous studies showed that SARS-CoV-2 is highly homologous to SARS-CoV and infects
Jiahua He +4 more
doaj +2 more sources
Peptide‐Based Inhibitors for SARS‐CoV‐2 and SARS‐CoV [PDF]
Advanced Therapeutics, 2021 AbstractThe COVID‐19 (coronavirus disease) global pandemic, caused by the spread of the SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2) virus, currently has limited treatment options which include vaccines, anti‐virals, and repurposed therapeutics. With their high specificity, tunability, and biocompatibility, small molecules like peptides
Disha Panchal +11 more
openaire +2 more sources
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics [PDF]
The Lancet Infectious Diseases, 2020 The objective of this Personal View is to compare transmissibility, hospitalisation, and mortality rates for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with those of other epidemic coronaviruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), and pandemic ...
Petersen E. +8 more
openaire +3 more sources
Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
Nature Communications, 2023 Abstract The phenomenon of protein aggregation is associated with a wide range of human diseases. Our knowledge of the aggregation behaviour of viral proteins, however, is still rather limited. Here, we investigated this behaviour in the SARS-CoV and SARS-CoV-2 proteomes.
Taniya Bhardwaj +14 more
openaire +4 more sources
Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins [PDF]
Bioinformatics and Biology Insights, 2021 SARS-CoV-2 virus, the causative agent of COVID-19 pandemic, has a genomic organization consisting of 16 nonstructural proteins (nsps), 4 structural proteins, and 9 accessory proteins. Relative of SARS-CoV-2, SARS-CoV, has genomic organization, which is very similar.
Ritesh Gorkhali +5 more
openaire +3 more sources
Epidemiology of SARS-CoV-2 [PDF]
Infection, 2020 Abstract Purpose SARS-CoV-2 is a recently emerged ß-coronavirus. Here we present the current knowledge on its epidemiologic features. Methods Non-systematic review.
Salzberger, Bernd +7 more
openaire +2 more sources
Comparison between SARS-CoV and SARS-CoV 2 [PDF]
E3S Web of Conferences, 2021 COVID-19, which is officially called SARS-CoV-2, is a newly emerging viral respiratory illness leading to a global epidemic, which causes concerns among the global community in November 2019. SARS-CoV-2 is considered as the third global coronavirus epidemic in the past 20 years after SARS-CoV in 2002 and MERS in 2012.
openaire +2 more sources